Bristol-Myers Squibb Co. (NYSE:BMY)
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
dividendsrus
(93.55)
Submitted: 2/10/2012 10:46:55 AM :
Start Price:
$31.83
BMY Score:
-0.43
Solid dividend payer should outperform over time.
Recs
pchop123
(70.47)
Submitted: 1/25/2012 11:14:08 AM :
Start Price:
$32.53
BMY Score:
-4.83
One of the best pipelines if not the best,with great PE/Yield #'s
Recs
fooluser17
(88.90)
Submitted: 1/19/2012 1:26:31 PM :
Start Price:
$32.64
BMY Score:
-4.88
Good numbers, good payout ratio, good debt, good cash on hand, good pipeline, good diversity of drugs, and good dividend. Probably make this one 2%.
Recs
kirovs
(34.79)
Submitted: 1/12/2012 11:05:24 AM :
Start Price:
$33.97
BMY Score:
+16.57
Valuation, patent cliff this year
Recs
Recs
cougarVF61
(39.13)
Submitted: 11/11/2011 9:00:19 PM :
Start Price:
$31.21
BMY Score:
-4.86
product line & mgm't innovations
Recs
Ptheforester
(52.58)
Submitted: 11/8/2011 6:05:52 PM :
Start Price:
$31.04
BMY Score:
-5.35
a strong pharma company with a good pipeline
Recs
MajorBob04
(74.63)
Submitted: 10/3/2011 5:30:28 PM :
Start Price:
$30.46
BMY Score:
-19.90
Buybacks and solid pipeline means price growth, or at least better performance than the S&P 500.
Recs
SnowBawl
(< 20)
Submitted: 9/9/2011 10:51:02 AM :
Start Price:
$28.91
BMY Score:
-4.39
Hillary says so.
Recs
GinaSB
(63.13)
Submitted: 8/11/2011 11:11:16 AM :
Start Price:
$27.00
BMY Score:
+0.81
Nice dividend.
Strong drug portfolio and healthy pipeline.
Cut operating costs, more cuts planned, and new drugs planned for release expected to offset patent losses in 2012-2015.
Recs
shirtface
(< 20)
Submitted: 8/9/2011 6:39:02 PM :
Start Price:
$26.34
BMY Score:
+4.01
Nice dividend return...
Recs
20100626
(< 20)
Submitted: 8/6/2011 5:01:47 AM :
Start Price:
$26.16
BMY Score:
+6.48
By Reader Request: Here's What to Buy If You're Opportunistic … but Still Scared - TMF staff
Recs
Wingaersheek
(57.30)
Submitted: 6/29/2011 9:16:40 AM :
Start Price:
$27.72
BMY Score:
+11.43
Bristol Myers is an undervalued company poised for even more growth and stability, as well as a solid dividend. The P/E is around 13, just about my benchmark, and the P/S is 2.5. Year over year we have seen a growth of 32.56% in EPS and enough cash to cover their dividend and grow that too or the company more.
Recs
RenoNV
(53.55)
Submitted: 6/24/2011 1:47:43 AM :
Start Price:
$28.35
BMY Score:
+7.30
QUALITY STOCK, NEW PRODUCT INTRODUCED, AND NICE DIVIDEND.
Recs
tbonci
(67.55)
Submitted: 5/25/2011 10:05:08 AM :
Start Price:
$27.20
BMY Score:
+14.73
BMY is in a solid business position. Their drug portfolio is wide-ranging and covers cardiovascular, HIV, cancer, and neuropathy. Their products (such as Plavix and Abilify) are well accepted by the Health Care industry and prescribed regularly. Looking forward, a new cancer drug was just approved in Europe, and many more drugs are in trials, including more promising cancer treatments.
Recs
thunderhawke23
(33.55)
Submitted: 4/4/2011 1:03:28 PM :
Start Price:
$25.92
BMY Score:
+21.79
Low debt/equity, very innovative pipeline pushed down over long time for previous malfeasance, also an attractive takeover target when legal issues finish
Recs
healthcarevalue
(96.65)
Submitted: 4/4/2011 1:00:10 PM :
Start Price:
$25.92
BMY Score:
+21.78
Low debt/equity, at 0.35. Reasonable price/earnings, at 14.95, which is low for historic levels of BMY. Market cap of 45.56 billion leaves some room to grow, but also indicates stability. However, the most single impressive track record of BMY is its historic positive and impressive values for Return on Invested Capital.
Recs
colddrink73
(98.84)
Submitted: 3/29/2011 10:05:11 PM :
Start Price:
$25.81
BMY Score:
+21.80
Ok I like the dividend I like a few of their products... and TrackJimCramer gives it a Red thumb. So you know it's on its way UP!!!
Recs
Timurfz
(20.13)
Submitted: 3/18/2011 4:52:42 AM :
Start Price:
$24.48
BMY Score:
+25.52
Pharmacy may have strong support this year in case of Japan catastrophe
Recs
godsend
(< 20)
Submitted: 1/15/2011 6:34:23 AM :
Start Price:
$24.78
BMY Score:
+24.31
value,growth,safety,innovation.......
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 233 : 1 2 3 4 5 6 7 8 9 10 Next »